IL1RAP (LAD191 Biosimilar) Recombinant Monoclonal Antibody
-
貨號:CSB-RA878844MB4HU
-
規(guī)格:¥83486
-
其他:
產(chǎn)品詳情
-
產(chǎn)品描述:IL1RAP (LAD191 Biosimilar Antibody)重組單克隆抗體是一款專為科研用途開發(fā)的生物試劑,其靶點為白細胞介素1受體輔助蛋白(IL1RAP)。該抗體通過重組DNA技術(shù)在哺乳動物細胞中表達,具有高純度、高特異性和批次間一致性的特點,為相關(guān)領(lǐng)域的基礎(chǔ)研究和機制探索提供可靠工具。 IL1RAP作為IL-1受體家族的重要組成部分,在炎癥反應(yīng)、免疫調(diào)節(jié)及多種疾病的病理過程中發(fā)揮關(guān)鍵作用。本產(chǎn)品可廣泛應(yīng)用于某些實驗,助力研究人員深入解析IL1RAP在信號通路中的功能,以及其與自身免疫性疾病、腫瘤微環(huán)境調(diào)控等生理病理過程的關(guān)聯(lián)。 該抗體經(jīng)嚴格的質(zhì)量控制流程,包括蛋白純度檢測(SDS-PAGE)、活性驗證(ELISA結(jié)合實驗)及內(nèi)毒素含量監(jiān)測,確保符合科研實驗的高標準要求。其穩(wěn)定的生物學活性和可重復(fù)性,為長期實驗和多中心研究提供有力支持。 使用時需注意按照推薦濃度稀釋,并根據(jù)具體實驗需求優(yōu)化反應(yīng)條件。產(chǎn)品儲存于-20℃環(huán)境下可保持穩(wěn)定,避免反復(fù)凍融。通過特異性識別IL1RAP,此抗體為揭示其在細胞信號轉(zhuǎn)導(dǎo)、炎癥應(yīng)答及疾病發(fā)生發(fā)展中的分子機制提供了重要研究手段,適用于免疫學、細胞生物學及轉(zhuǎn)化醫(yī)學等多個研究領(lǐng)域。
-
Uniprot No.:
-
基因名:
-
別名:LAD-191 research-grade biosimilar ;IL1RAP antibody; C3orf13 antibody; IL1R3 antibody; Interleukin-1 receptor accessory protein antibody; IL-1 receptor accessory protein antibody; IL-1RAcP antibody; EC 3.2.2.6 antibody; Interleukin-1 receptor 3 antibody; IL-1R-3 antibody; IL-1R3 antibody
-
反應(yīng)種屬:Human
-
免疫原:Recombinant Human IL1RAP protein
-
免疫原種屬:Homo sapiens (Human)
-
標記方式:Non-conjugated
-
克隆類型:Monoclonal
-
濃度:It differs from different batches. Please contact us to confirm it.
-
保存緩沖液:0.01M PBS,pH7.4
-
產(chǎn)品提供形式:Liquid
-
應(yīng)用說明:Validation Status
Application-specific performance (e.g., in flow cytometry, ELISA, IHC or other assay formats) has not yet been experimentally verified by CUSABIO. Users are advised to determine the optimal working conditions empirically in their own assay systems.
Guaranteed Quality
① Antibody purity?> 95% tested by SDS-PAGE.
② Endotoxin level < 0.1EU/ug tested by LAL method. -
儲存條件:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期:3-4 weeks
-
用途:It is a non-therapeutic biosimilar antibody, owning the same variable region from the corresponding approved therapeutic antibody. In conclusion, it is a research-grade biosimilar antibody and expressed in mammalian cell, which can be directly used as positive controls in drug discovery or used for rapid verification of the biological functions of target protein.
相關(guān)產(chǎn)品
靶點詳情
-
功能:Coreceptor for IL1RL2 in the IL-36 signaling system. Coreceptor with IL1R1 in the IL-1 signaling system. Associates with IL1R1 bound to IL1B to form the high affinity interleukin-1 receptor complex which mediates interleukin-1-dependent activation of NF-kappa-B and other pathways. Signaling involves the recruitment of adapter molecules such as TOLLIP, MYD88, and IRAK1 or IRAK2 via the respective TIR domains of the receptor/coreceptor subunits. Recruits TOLLIP to the signaling complex. Does not bind to interleukin-1 alone; binding of IL1RN to IL1R1, prevents its association with IL1R1 to form a signaling complex. The cellular response is modulated through a non-signaling association with the membrane IL1R2 decoy receptor. Coreceptor for IL1RL1 in the IL-33 signaling system. Can bidirectionally induce pre- and postsynaptic differentiation of neurons by trans-synaptically binding to PTPRD. May play a role in IL1B-mediated costimulation of IFNG production from T-helper 1 (Th1) cells (Probable).; Associates with secreted ligand-bound IL1R2 and increases the affinity of secreted IL1R2 for IL1B; this complex formation may be the dominant mechanism for neutralization of IL1B by secreted/soluble receptors. Enhances the ability of secreted IL1R1 to inhibit IL-33 signaling.; Unable to mediate canonical IL-1 signaling. Required for Src phosphorylation by IL1B. May be involved in IL1B-potentiated NMDA-induced calcium influx in neurons.
-
基因功能參考文獻:
- Expression level of sIL1RAP may become one of the potential indexes for determining the prognosis of low-grade gliomas PMID: 29238884
- These results provide novel insights into the role of IL1RAP in CML and a strong rationale for the development of an IL1RAP antibody therapy to target residual CML stem cells. PMID: 27621309
- single nucleotide polymorphism A471T in the Toll-interleukin 1 receptor domain (TIR) of the IL-1Rrp2 that is present in approximately 2% of the human population, down-regulated IL-36R signaling by a decrease of interaction with IL-1RAcP. PMID: 27307043
- The findings of this study support IL1RAP as a novel potential Alzheimer's disease target and highlight the use of amyloid PET as a valuable Alzheimer's disease endophenotype, particularly in a longitudinal framework. PMID: 26268530
- The SNP rs4624606 in IL-1RAcP was nominally associated with CAD risk. PMID: 25517029
- Data suggest serum levels of soluble IL1RAP (from alternative splicing) are down-regulated in endometriosis throughout menstrual cycle; IL1RAP levels (which peak in proliferative phase in fertile women) exhibit minor variations in endometriosis. PMID: 24935223
- Plasma sIL1RAP levels are reduced in obesity and can potentially act as biomarkers of obesity. PMID: 24915116
- Combined crystallography and small-angle X-ray-scattering studies reveal that ST2 possesses hinge flexibility between the D3 domain and D1D2 module, whereas IL-1RAcP exhibits a rigid conformation in the unbound state in solution. PMID: 23980170
- Knockdown of IL1RAP decreased clonogenicity and increased cell death of AML cells. PMID: 22723552
- Interleukin-1R3 mediates interleukin-1-induced potassium current increase through fast activation of Akt kinase. PMID: 22778412
- decreased protein levels in the peritoneal fluid of women with endometriosis PMID: 21958553
- Studies indicate that new targets have recently been investigated as potential modulators in myeloid leukemia pathogenesis, including miR-328, BMI1, FOXOs and IL1RAP. PMID: 21373837
- This study showed a significant downregulation of soluble interleukin-1 receptor accessory protein expression in the endometrium of women with endometriosis. PMID: 21272866
- identifies IL1RAP as a unique cell surface biomarker distinguishing Ph(+) from Ph(-) candidate chronic myeloid leukemia (CML) stem cells and opens up a previously unexplored avenue for therapy of CML PMID: 20805474
- Identification of essential regions in the cytoplasmic tail of interleukin-1 receptor accessory protein critical for interleukin-1 signaling PMID: 11880380
- soluble form of IL-1R AcP contributes to the antagonism of IL-1 action by the type II decoy receptor PMID: 12530978
- The dramatic changes in levels of IL-1RAcP mRNAs suggest important functions in regulating sensitivity to IL-1 during stress and may play a role in oncogenic processes that are engaged during chronic inflammation. PMID: 12781872
- IL-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP in Jurkat cells PMID: 14734551
- Specific destabilization of membrane-bound IL-1 receptor accessory protein mRNA in HepG2 hepatoma cells is mediated by its 2.8-kilobase 3'-untranslated region. PMID: 15528363
- Analysis of a three-dimensional docking model of the TIR-TIR interaction between MyD88 and IL1RAcP PMID: 15849357
- IL-1ra is associated with preserved beta-cell capacity in type 1 diabetes. PMID: 18299313
- an isoform of the IL-1 receptor accessory protein (termed AcPb) was identified that is expressed exclusively in the CNS. PMID: 19481478
顯示更多
收起更多
-
亞細胞定位:[Isoform 1]: Cell membrane; Single-pass type I membrane protein.; [Isoform 2]: Secreted.; [Isoform 3]: Secreted.
-
蛋白家族:Interleukin-1 receptor family
-
組織特異性:Detected in liver, skin, placenta, thymus and lung. Isoform 4 is predominantly expressed in brain. Overexpressed on candidate chronic myeloid leukemia (CML) stem cells, hematopoietic stem cells and mononuclear cells of patients with acute myeloid leukemia
-
數(shù)據(jù)庫鏈接:
Most popular with customers
-
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC, IF, FC
Species Reactivity: Human, Mouse, Rat
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-















